Agreed Hovacre, all this negativity is premature. As Mark Twain said, "The rumors of my death have been greatly exagerrated." The last I checked ADXS is still a late stage company with an ongoing Phase 3 trial in cervical cancer.
At these levels I'm reluctant to think it's anything but negative. The 2017 registration was a much different time for ADXS...
Any thoughts on them adding all the additional securities to the shelf including debt, preferred, warrants, units, etc.? I really hope they're not looking to offer preferred shares.. I guess time will tell.